Clinical Trials
Tucatinib in Combination w/Doxil for HER2+ metastatic breast cancer
Disease Type: Breast
Phase 2 Single Arm Trial with a Safety Lead-in of Tucatinib in Combination with Doxil for the Treatment of HER2+ Metastatic Breast Cancer (BRE 381)
Locations
Alleghany , Blacksburg , Roanoke , Salem , Wytheville